Although blood GFAP seems like a viable alternative for capturing the brain changes for forecasting disease progression, there is still a lot of endeavor that needs to be undertaken to cement its potential as a trustworthy marker in AD. The gene discussed is GFAP; the disease is Alzheimer disease.